More than 8 million people globally suffer from type 1 diabetes, a condition where the immune system destroys ...

Patients and employers say damage is done by surging health care costs that have gone well past state benchmarks.

US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro, its widely used diabetes and weight-loss ...